| Patent | Date |
|---|
Pharmaceutical Composition For Subcutaneous Injection Comprising Human Hyaluronidase Ph20 Variant And Drug
App 20220289864 - PARK; Soon Jae ; et al. | 2022-09-15 |
Method for producing fusion protein having IgG Fc domain
Grant 11,414,476 - Park , et al. August 16, 2 | 2022-08-16 |
Antibody-drug Conjugate Comprising Modified Antibody
App 20220105197 - PARK; Soon Jae ; et al. | 2022-04-07 |
Antibody-drug conjugate comprising modified antibody
Grant 11,235,065 - Park , et al. February 1, 2 | 2022-02-01 |
Pharmaceutical Composition For Subcutaneous Injection Comprising Human Hyaluronidase Ph20 Variant And Drug
App 20210363270 - PARK; Soon Jae ; et al. | 2021-11-25 |
Method for providing smart key service and electronic device thereof
Grant 11,080,386 - Woo , et al. August 3, 2 | 2021-08-03 |
Novel Hyaluronidase Variants And Pharmaceutical Composition Comprising The Same
App 20210155913 - PARK; Soon Jae ; et al. | 2021-05-27 |
Antibody Specifically Binding To Folr1 And Uses Thereof
App 20210009685 - PARK; Soon Jae ; et al. | 2021-01-14 |
Novel Growth Hormone Receptor Antagonist And Fusion Protein Thereof
App 20200399340 - PARK; Soon Jae ; et al. | 2020-12-24 |
Antibody-drug Conjugate Comprising Modified Antibody
App 20200254111 - Kind Code | 2020-08-13 |
Method For Providing Smart Key Service And Electronic Device Thereof
App 20190065732 - Woo; Jeong ; et al. | 2019-02-28 |
Method For Producing Fusion Protein Having Igg Fc Domain
App 20180298078 - PARK; Soon Jae ; et al. | 2018-10-18 |
Stable liquid formulation of fusion protein with IgG Fc domain
Grant 9,982,032 - Park , et al. May 29, 2 | 2018-05-29 |
Method of purifying a long-acting human growth hormone
Grant 9,902,753 - Kang , et al. February 27, 2 | 2018-02-27 |
Composition for stabilizing protein and pharmaceutical formulation comprising the same
Grant 9,821,059 - Park , et al. November 21, 2 | 2017-11-21 |
Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for same
Grant 9,814,782 - Park , et al. November 14, 2 | 2017-11-14 |
Modified Antibody In Which Motif Comprising Cysteine Residue Is Bound, Modified Antibody-drug Conjugate Comprising The Modified Antibody, And Production Method For Same
App 20170119903 - Park; Soon Jae ; et al. | 2017-05-04 |
STABLE LIQUID FORMULATION OF FUSION PROTEIN WITH IgG Fc DOMAIN
App 20160376342 - Park; Soon Jae ; et al. | 2016-12-29 |
Composition for stabilizing fusion protein in which protein and FC domain are fused
Grant 9,474,803 - Park , et al. October 25, 2 | 2016-10-25 |
Composition For Stabilizing Protein And Pharmaceutical Formulation Comprising The Same
App 20160114036 - Park; Soon Jae ; et al. | 2016-04-28 |
Modified Antibody In Which Motif Comprising Cysteine Residue Is Bound, Modified Antibody-drug Conjugate Comprising The Modified Antibody, And Production Method For Same
App 20160102148 - Park; Soon Jae ; et al. | 2016-04-14 |
Composition For Stabilizing Fusion Protein In Which Protein And Fc Domain Are Fused
App 20150313996 - Park; Soon Jae ; et al. | 2015-11-05 |
Alpha-1 antitrypsin variant, preparation method thereof and use thereof
Grant 9,051,395 - Park , et al. June 9, 2 | 2015-06-09 |
Highly Glycosylated Long-Acting Human Growth Hormone Protein and Production Method for Same
App 20150126715 - Kang; Gil Bu ; et al. | 2015-05-07 |
Novel Alpha-1 Antitrypsin Variant, Preparation Method Thereof And Use Thereof
App 20140371160 - Park; Soon Jae ; et al. | 2014-12-18 |
Method and system for testing a display panel assembly
Grant 7,860,296 - Kwon , et al. December 28, 2 | 2010-12-28 |
Method and system for testing a display panel assembly
App 20060120588 - Kwon; Sang-Hyuk ; et al. | 2006-06-08 |
Process for purifying hepatitis B viral surface antigen comprising pres2 peptide
Grant 6,362,320 - Park , et al. March 26, 2 | 2002-03-26 |
| 